Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Aouizerate

Showing results (111-120 of 127) with videos related to

Pageof 13
Sort By:
Brain, Behavior, & Immunity - Health|April 26, 2022
Immuno-metabolic profile of patients with psychotic disorders and metabolic syndrome. Results from the FACE-SZ cohortMarianne Foiselle, Susana Barbosa, Ophélia Godin, et al.
Brain Sciences|December 16, 2020
Treatment-Resistant Depression in a Real-World Setting: First Interim Analysis of Characteristics, Healthcare Resource Use, and Utility Values of the FondaMental CohortAntoine Yrondi, Djamila Bennabi, Emmanuel Haffen, et al.
Journal of Affective Disorders|February 26, 2023
Diurnal symptoms of sleepiness and dysfunction predict future suicidal ideation in a French cohort of outpatients (FACE-DR) with treatment resistant depression: A 1-year prospective study about sleep markersJulia Maruani, Fanny Molière, Ophelia Godin, et al.
Journal of Psychosomatic Research|June 25, 2025
Clinical and inflammatory markers associated with metabolic dysfunction-associated fatty liver disease in a cohort of individuals with chronic schizophrenia (FACE-SZ)Rudy Tokarski, Susana Barbosa, Baptiste Pignon, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|January 21, 2022
Precision-medicine findings from the FACE-SZ cohort to develop motivation-enhancing programs in real-world schizophreniaThéo Korchia, Maud Tastevin, Pierre-Louis Sunhary de Verville, et al.
The Lancet. Neurology|June 25, 2017
Anterior pallidal deep brain stimulation for Tourette's syndrome: a randomised, double-blind, controlled trialMarie-Laure Welter, Jean-Luc Houeto, Stéphane Thobois, et al.
Psychiatry Research|June 3, 2025
Pro-inflammatory processes and metabolic syndrome: combined risk of resistance to treatment in patients with schizophrenia from the FACE-SZ cohortKaori Saitoh, Mohamed Lajnef, Wahid Boukouaci, et al.
Brain Sciences|July 29, 2023
Evolution of Cognitive Impairments in Treatment-Resistant Depression: Results from the Longitudinal French Centers of Expertise for Treatment-Resistant Depression (FACE-DR) CohortAlexis Vancappel, Yecodji Dansou, Ophelia Godin, et al.
The New England Journal of Medicine|November 14, 2008
Subthalamic nucleus stimulation in severe obsessive-compulsive disorderLuc Mallet, Mircea Polosan, Nematollah Jaafari, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 1, 2025
Prediction of relapse in a French cohort of outpatients with schizophrenia (FACE-SZ): Prediction, not associationSusana Barbosa, Ryad Tamouza, Marion Leboyer, et al.
Pageof 13

Showing results (111-120 of 127) with videos related to

Sort By:
Pageof 13
Brain, Behavior, & Immunity - Health|April 26, 2022
Immuno-metabolic profile of patients with psychotic disorders and metabolic syndrome. Results from the FACE-SZ cohortMarianne Foiselle, Susana Barbosa, Ophélia Godin, et al.
Brain Sciences|December 16, 2020
Treatment-Resistant Depression in a Real-World Setting: First Interim Analysis of Characteristics, Healthcare Resource Use, and Utility Values of the FondaMental CohortAntoine Yrondi, Djamila Bennabi, Emmanuel Haffen, et al.
Journal of Affective Disorders|February 26, 2023
Diurnal symptoms of sleepiness and dysfunction predict future suicidal ideation in a French cohort of outpatients (FACE-DR) with treatment resistant depression: A 1-year prospective study about sleep markersJulia Maruani, Fanny Molière, Ophelia Godin, et al.
Journal of Psychosomatic Research|June 25, 2025
Clinical and inflammatory markers associated with metabolic dysfunction-associated fatty liver disease in a cohort of individuals with chronic schizophrenia (FACE-SZ)Rudy Tokarski, Susana Barbosa, Baptiste Pignon, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|January 21, 2022
Precision-medicine findings from the FACE-SZ cohort to develop motivation-enhancing programs in real-world schizophreniaThéo Korchia, Maud Tastevin, Pierre-Louis Sunhary de Verville, et al.
The Lancet. Neurology|June 25, 2017
Anterior pallidal deep brain stimulation for Tourette's syndrome: a randomised, double-blind, controlled trialMarie-Laure Welter, Jean-Luc Houeto, Stéphane Thobois, et al.
Psychiatry Research|June 3, 2025
Pro-inflammatory processes and metabolic syndrome: combined risk of resistance to treatment in patients with schizophrenia from the FACE-SZ cohortKaori Saitoh, Mohamed Lajnef, Wahid Boukouaci, et al.
Brain Sciences|July 29, 2023
Evolution of Cognitive Impairments in Treatment-Resistant Depression: Results from the Longitudinal French Centers of Expertise for Treatment-Resistant Depression (FACE-DR) CohortAlexis Vancappel, Yecodji Dansou, Ophelia Godin, et al.
The New England Journal of Medicine|November 14, 2008
Subthalamic nucleus stimulation in severe obsessive-compulsive disorderLuc Mallet, Mircea Polosan, Nematollah Jaafari, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 1, 2025
Prediction of relapse in a French cohort of outpatients with schizophrenia (FACE-SZ): Prediction, not associationSusana Barbosa, Ryad Tamouza, Marion Leboyer, et al.
Pageof 13